 |
|
|


|
Interesting ECG
[April 17, 09:15-10:45 Rm.103]
|
|
| Chairpersons |
노태호, 조정관 |
| Speakers |
김유리/가톨릭의대, 문희선/한림의대, 박준범/연세의대, 신승용/중앙의대, 엄재선/연세의대, 조영진/서울의대 |
|
Myocardial Infarction 1
[April 17, 09:30-10:45 Rm.104]
|
|
| How to Analyze and Write Good Papers from a Big Registry Data |
| Chairpersons |
김종진, 조명찬 |
| Panel |
강현재, 나득영, 정진옥, 황진용 |
| 09:30-09:45 |
Sharing Experiences: How to Analysis Data from KORMI/KAMIR |
나승운/고려의대 |
| 09:45-10:10 |
Analysis of HIRA-Claim Data |
이중엽/서울의대 |
| 10:10-10:35 |
Dealing with Confounding in the Analysis of Registry Data |
윤성철/울산의대 |
| 10:35-10:45 |
Discussion |
|
Imaging 1
[April 17, 09:30-10:45 Rm.205]
|
|
| Screening Value of Imaging of High-Risk Subjects for Cardiovascular Disease |
| Chairpersons |
조인호, 김태훈 |
| Panel |
박재형, 유승민, 원경숙 |
| 09:30-09:50 |
Coronary CT and Calcium CT ? The Resolution for Cardiovascular Screening |
최상일/서울의대 |
| 09:50-10:10 |
Echocardiography for Screening in Preoperative and High-Risk Subjects |
김은경/성균관의대 |
| 10:10-10:30 |
SPECT or PET for Cardiovascular Screening in High-Risk Subjects |
팽진철/서울의대 |
| 10:30-10:45 |
Discussion |
|
CHF 2
[April 17, 10:55-12:20 Rm.201]
|
|
| Heart Failure : Factors for the Progression and Reversal of Clinical Course |
| Chairpersons |
김재중, 최동주 |
| Panel |
강석민, 김동수, 김용진, 양동헌, 유병수 |
| 10:55-11:10 |
Myocardial Ischemia in HFrEF |
한성우/한림의대 |
| 11:10-11:25 |
Reverse Remodeling of Heart Failure |
김계훈/전남의대 |
| 11:25-11:40 |
Atrial Fibrillation and Decompensated Heart Failure |
김성환/가톨릭의대 |
| 11:40-12:05 |
Keynote Lecture: Heart Failure: The Recent Advances |
John J.V. Mcmurray/ Glasgow Univ., UK |
| 12:05-12:20 |
Discussion |
|
Imaging 2
[April 17, 10:55-12:20 Rm.205]
|
|
| Recent Controversial Issues in Cardiovascular Perfusion Imaging |
| Chairpersons |
최연현, 송재관 |
| Panel |
강원준,이상철,허진 |
| 10:55-11:20 |
Myocardial CT Perfusion: The New One-Stop Shop for Ischemic Heart Disease |
양동현/울산의대 |
| 11:20-11:45 |
The Prime for MR Cardiac Perfusion |
추기석/부산의대 |
| 11:45-11:55 |
Rebuttal by Presenter 1 |
| 11:55-12:05 |
Rebuttal by Presenter 2 |
| 12:05-12:20 |
Discussion |
|
Scientific Session 1 [Boryung]
[April 17, 12:30-13:10 Rm.103]
|
|
| Optimal BP Control: The Latest ARB |
| Chairpersons |
김권삼, 채성철 |
| 12:30-12:50 |
Effect of RAS Inhibition in Metabolic Syndrome: The Korean Perspective from K-Mets Study |
정우백/가톨릭의대 |
| 12:50-13:10 |
The Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients with Essential HTN |
한성욱/계명의대 |
|
Scientific Session 3 [Boehringer Ingelheim]
[April 17, 12:30-13:10 Rm.205]
|
|
| Chairpersons |
김효수, 신동구 |
| Reassuring Real World Data of Dabigatran and Thromboembolic Protection Across Indications |
| 12:30-12:50 |
Real World Treatment Experience with Dabigatran Etexilate for Stroke Prevention in AF |
박형욱/전남의대 |
| 12:50-13:10 |
Dabigatran Etexilate for the Treatment of Acute DVT/PE and Prevention of Recurrence |
고영국/연세의대 |
|
Suh, Soon-Kyu Memorial Lecture
[April 17, 14:30-15:15 Rm.103]
|
|
| Chairperson |
김영조 |
| 14:30-15:10 |
Diet, Herbs and Supplements: What Works |
C. Noel Bairey Merz/ Cedars-Sinai Medical Center, USA |
| 15:10-15:15 |
Discussion |
|
Plenary Session
[April 17, 15:15-16:00 Rm.103]
|
|
| Chairperson |
오병희 |
| 15:15-15:55 |
ARNI: A True Paradigm Shift in HF Management |
John McMurray/ Glasgow Univ., UK |
| 15:55-16:00 |
Discussion |
|
Allied Professional 1
[April 17, 16:15-17:45 Rm.201]
|
|
| Cardiac Arrhythmia Diagnostics |
| Chairpersons |
최현철, 고경정 |
| 16:15-16:45 |
SVT vs. VT Differential Diagnosis |
박종성/동아의대 |
| 16:45-17:15 |
Tilt-Table Test : Protocols and Diagnostic Efficacy |
박정왜/삼성서울병원 |
| 17:15-17:45 |
Radiation Exposure in the Cath Lab-Safety and Precautions |
강준원/고대안암병원 |
|
Women's Heart Disease
[April 17, 16:15-17:45 Rm.205]
|
|
| Women and Ischemic Heart Disease |
| Chairpersons |
심완주, 김순길 |
| Panel |
신미승, 손일석, 홍경순 |
| 16:15-16:45 |
Detection, Diagnosis and Management |
C. Noel Bairey Merz/Cedars-Sinai Medical Center, USA |
| 16:45-17:05 |
Pathophysiology : Vasospasm and Microvascular Angina |
박성미/고려의대 |
| 17:05-17:25 |
Gender Specific Risk Factors for Ischemic Heart Disease |
김학령/서울의대 |
| 17:25-17:45 |
Discussion |
|
Congenital Heart Disease 1
[April 18, 08:30-10:00 Rm.203]
|
|
| Natural and Unnatural History of Adults with Congenital Heart Disease |
| Chairpersons |
노정일, 고재곤 |
| Panel |
김계훈, 김성호, 배은정, 송종민 |
| 08:30-08:50 |
Prevalence of Adult Congenital Heart Disease (ACHD) |
정조원/연세의대 |
| 08:50-09:10 |
Trends in Survival and Mortality in Current Era |
길홍량/충남의대 |
| 09:10-09:30 |
Cardiopulmonary Variables During Exercise in Adult Patients with Congenital Heart Disease |
Hideo Ohuchi/National Cardiovascular Center, Japan |
| 09:30-09:50 |
Quality of Life in Adults with CHD |
박승우/성균관의대 |
| 09:50-10:00 |
Discussion |
|
Scientific Session 4 [Bayer]
[April 18, 12:00-12:40 Rm.103]
|
|
| Rivaroxaban in Cardiology: Current Practice and Exploring Future Directions |
| Chairpersons |
김영대, 이문형 |
| 12:00-12:20 |
New Trends and Treatment of Novel Oral Anticoagulants in AF Patients Undergoing Cardioversion |
박희남/연세의대 |
| 12:20-12:40 |
Simple to Start, Easy to Maintain for VTE Treatment |
김계훈/전남의대 |
|
Health Policies on CVD
[April 18, 13:00-13:50 Rm.201]
|
|
| Health Policies on CVD: What's New? |
| Chairpersons |
조명찬, 김효수 |
| 13:00-13:15 |
심뇌혈관종합대책: 10년간의 경과와 향후 계획
(National Action Plan to Prevent Heart Disease and Stroke: A Decade of Progress and Outlook for the Future) |
이재용/ 보건복지부 질병정책과 |
| 13:15-13:30 |
심혈관질환예방을 위한 만성질환예방 및 관리사업의 성과와 숙제 (Community-Based Initiatives for CVD Prevention) |
정율원/ 질병관리본부 만성질환관리과 |
| 13:30-13:45 |
CVD 예방관리를 위한 R&D (Prioritized Research Agenda for Evidence-Based CVD Prevention and Care) |
박현영/ 국립보건연구원 심혈관희귀질환과 |
|
Mobile Healthcare Knocks on Your Clinic
[April 18, 14:00-15:30 Rm.201]
|
|
| Mobile Healthcare Knocks on Your Clinic |
| Chairpersons |
김영조, 박승우 |
| 14:00-14:15 |
모바일헬스케어 소개 |
정지훈/경희사이버대 |
| 14:15-14:30 |
모바일헬스케어의 기술 |
박은성/ 삼성전자 종합기술원 |
| 14:30-14:45 |
모바일헬스케어의 경험 |
육태선/ SK텔레콤 신사업추친단 |
| 14:45-15:00 |
모바일헬스케어 정책 |
구혁채/ 미래창조과학부 창조융합기획과 |
| 15:00-15:15 |
눈앞에 닥친 모바일 헬스케어 |
박승우/성균관의대 |
| 15:15-15:30 |
Discussion |
|
Basic Research 2
[April 18, 15:45-17:15 Rm.201]
|
|
| Signaling Mechanisms |
| Chairpersons |
오구택, 박현영 |
| Panel |
임병관, 조현재, 한승환 |
| 15:45-16:05 |
Tetrahydrobiopterin-Induced Cardioprotective Signaling Mechanism |
한진/인제의대 |
| 16:05-16:25 |
Posttranslational Modification of Histone Deacetylase 2 in Cardiac Hypertrophy |
국현/전남의대 |
| 16:25-16:45 |
Role of Formyl Peptide Receptor 2 in Therapeutic Angiogenesis |
김재호/부산의대 |
| 16:45-17:05 |
ROS Signaling in Atherosclerosis via Impaired Autophagy |
오구택/이화여대 |
| 17:05-17:15 |
Discussion |
|
Congenital Heart Disease 4
[April 18, 15:45-17:15 Rm.203]
|
|
| New Medication & Treatment |
| Chairpersons |
김용진(서울의대, 흉부외과), 김남수 |
| Panel |
송민섭, 송진영, 심우섭, 조준용, 최재영 |
| 15:45-16:05 |
New Cardiovascular Drugs for Pediatric Heart Failure |
하기수/고려의대 |
| 16:05-16:25 |
New Drugs for Pulmonary Hypertension
|
김기범/서울의대 |
| Pros & Cons : Late Failure of Fontan Circulation |
| 16:25-16:45 |
- Fontan Takedown, and Conversion to Two Ventricle |
이창하/세종병원 |
| 16:45-17:05 |
- Heart Transplantation |
박정준/울산의대 |
| 17:05-17:15 |
Discussion |
|
Vascular Disease
[April 18, 15:45-17:15 Rm.205]
|
|
| Contribution of Arterial Stiffness to the Development of Hypertension: from Bench to Bedside |
| Chairpersons |
정진원, 박정배 |
| 15:45-16:15 |
Aortic Stiffness, Blood Pressure Progression and Incident Hypertension |
Boutouyrie Pierre/ HEGP Hopital Europeen, France |
| 16:15-16:35 |
Can Exercise Reduce Arterial Stiffness in Hypertensives? |
제세영/서울시립대 |
| 16:35-16:55 |
Vascular Calcification: A Novel Mechanism for Aortic Stiffness in Hypertension |
김응주/고려의대 |
| 16:55-17:15 |
Interplay of Inflammation and Oxidative Stress in Aortic Stiffening |
박성하/연세의대 |

|
KSE 1
[April 17, 14:30-16:00 Rm.104]
|
|
| Issues & Updates in Valvular Heart Disease |
| Chairpersons |
심완주, 채성철 |
| 14:30-14:50 |
Bicuspid Aortic Valve: Pathogenesis & Clinical Significance |
송재관/울산의대 |
| 14:50-15:10 |
Paradoxical Low Gradient Severe AS: Causes & Prognostic Implication |
김용진/서울의대 |
| 15:10-15:30 |
Secondary Mitral Regurgitation: Severity Assessment & Management |
권준/인하의대 |
| 15:30-15:50 |
Marfan Syndrome: Diagnosis & Management |
박승우/성균관의대 |
| 15:50-16:00 |
Discussion |
|
KSE 2
[April 17, 16:15-17:45 Rm.103]
|
|
| Learning from Cases & Echocardiography |
| Chairpersons |
장경식, 신준한 |
| Panel |
김신재, 서정숙, 최의영 |
| 16:15-16:35 |
Mitral Valve Disease |
박태호/동아의대 |
| 16:35-16:55 |
Aortic Valve Disease |
박성지/성균관의대 |
| 16:55-17:15 |
Tricuspid Valve Disease |
홍그루/연세의대 |
| 17:15-17:35 |
Infective Endocarditis |
강덕현/울산의대 |
| 17:35-17:45 |
Discussion |
|
KSE 3
[April 18, 10:15-11:45 Rm.104]
|
|
| Issue & Updates in Myocardial & Pericardial Disease |
| Chairpersons |
손대원, 김기식 |
| 10:15-10:35 |
Cardiac Amyloidosis: Diagnostic Tools & Management |
이승표/서울의대 |
| 10:35-10:55 |
Hypertrophic Cardiomyopathy: Differential Diagnosis & Management |
김우식/경희의대 |
| 10:55-11:15 |
Tuberculous Pericarditis: Diagnosis & Management |
송종민/울산의대 |
| 11:15-11:35 |
Constrictive Pericarditis: Transient & Reversible Constriction |
김계훈/전남의대 |
| 11:35-11:45 |
Discussion |
|
KSE 4
[April 18, 14:00-15:30 Rm.205]
|
|
| Learning from Cases & Echocardiography |
| Chairpersons |
박종춘, 윤호중 |
| Panel |
김성환, 이선화, 최정현 |
| 14:00-14:20 |
Hypertrophic Cardiomyopathy |
양동헌/경북의대 |
| 14:20-14:40 |
Stress Cardiomyopathy |
한성우/한림의대 |
| 14:40-15:00 |
Myocarditis/Myocardial Infiltration |
조구영/서울의대 |
| 15:00-15:20 |
Pericardial Disease |
이상철/성균관의대 |
| 15:20-15:30 |
Discussion |

|
KSLA 1
[April 17, 09:15-10:45 Rm.203] |
|
| Vascular Research in Cardiovascular Disease |
| Chairpersons |
최영길, 김양하 |
| Panel |
강신애, 김오연, 박성하, 임수, 조경현 |
| 09:15-09:40 |
Immunosenescence and Vascular Aging |
신의철/한국과학기술원 |
| 09:40-10:05 |
Role of PCSK9 in Uptake and Degradation of LDL Particles |
박상욱/연세의대 |
| 10:05-10:30 |
Metabolomic Profiling for the Metabolism and Atherogenesis |
황금숙/한국기초과학지원연구원 |
| 10:30-10:45 |
Discussion |
|
KSLA 2
[April 17, 10:55-12:20 Rm.203]
|
|
| Metabolism and Brain |
| Chairpersons |
신현호, 서홍석 |
| Panel |
김용재, 박광열, 오구택, 이은정, 최성희 |
| 10:55-11:20 |
Metabolic Actions of Rho-Kinase in Periphery and Brain |
Young-Bum Kim/Harvard Univ., USA |
| 11:20-11:45 |
Possible Role of Low-dose PPAR-γ Agonist through LRP1 Regulation in Alzheimer’s Disease |
차봉수/연세의대 |
| 11:45-12:10 |
The Role of Free Fatty Acid in Ischemic Stroke |
서우근/고려의대 |
| 12:10-12:20 |
Discussion |
|
KSLA 3
[April 17, 14:30-16:00 Rm.203]
|
|
| Update of Cholesterol Treatment Guidelines |
| Chairpersons |
김치정, 박경수 |
| Panel |
김대중, 김병진, 김용석, 송기호, 이상학 |
| 14:30-14:55 |
Review of Updated Korean Cholesterol Treatment Guidelines and Others |
김상현/서울의대 |
| 14:55-15:20 |
Should We Apply Subclinical Atherosclerosis as a Marker for CVD Risk? |
한기훈/울산의대 |
| 15:20-15:45 |
CVD Risk Calculators: What Are Their Positions in the Clinical Practice? |
정창희/울산의대 |
| 15:45-16:00 |
Discussion |
|
KSLA 4
[April 17, 16:15-17:45 Rm.203]
|
|
| Special Debate Session: "A Patient with Type 2 Diabetes without Any History of Cardiovascular Disease and Already on Statin with LDL-C < 100 mg/dL, but Still High TG and Low HDL-C. What's Next?" |
| Chairpersons |
이문규 |
| Panel |
김재택, 김혜진, 서지아, 조상호, 최소연 |
| 16:15-16:25 |
Introduction |
이문규/성균관의대 |
| 16:25-16:50 |
Increase the Statin Dosage |
성기철/성균관의대 |
| 16:50-17:15 |
Add Fibrates |
김성래/가톨릭의대 |
| 17:15-17:40 |
Discussion |
| 17:40-17:45 |
Voting and Conclusion |

|
KSIC 1
[April 18, 08:30-9:50 Rm.103] |
|
| For Young Interventionist : Basic Techniques for Coronary Intervention |
| Chairpersons |
양주영, 채인호 |
| Panel |
김기석, 박종선, 박훈준, 전국진, 홍영준 |
| 08:30-08:42 |
Puncture Technique and Hemostasis (Femoral and Radial) |
김상민/충북의대 |
| 08:42-08:54 |
Selection of Guiding Catheter According to Artery |
신동호/연세의대 |
| 08:54-09:06 |
Selection of Guidewire According to Lesion |
김승환/을지의대 |
| 09:06-09:18 |
Optimal Stenting for Bifurcated Lesion |
송영빈/성균관의대 |
| 09:18-09:30 |
Optimal Stenting for Calcified Tortuous Lesion |
윤혁준/계명의대 |
| 09:30-09:50 |
Discussion |
|
KSIC 2
[April 18, 10:15-11:45 Rm.103]
|
|
| How Can We Decrease Infarction Size? |
| Chairpersons |
안태훈, 김병옥 |
| Panel |
강웅철, 강현재, 권기환, 유승기, 윤영원 |
| 10:15-10:35 |
Ischemic Injury and Reperfusion Injury |
서정원/서울의대 |
| 10:35-10:55 |
Drug Therapy |
이장훈/경북의대 |
| 10:55-11:15 |
Interventional Treatment |
이봉기/강원의대 |
| 11:15-11:35 |
Cell and Future Therapy |
배장환/충북의대 |
| 11:35-11:45 |
Discussion |
|
KSIC 3
[April 18, 14:00-15:30 Rm.104]
|
|
| Limitations ; What You Have to Know |
| Chairpersons |
탁승제, 김두일 |
| Panel |
구본권, 김병극, 안영근, 이재환, 임영효 |
| 14:00-14:17 |
Limitation of CAG, What You Have to Know |
채제건/전북의대 |
| 14:17-14:34 |
Limitation of IVUS, What You Have to Know |
이봉렬/대구파티마병원 |
| 14:34-14:51 |
Limitation of OCT, What You Have to Know |
최소연/아주의대 |
| 14:51-15:08 |
Limitation of FFR, What You Have to Know |
도준형/인제의대 |
| 15:08-15:30 |
Discussion |
|
KSIC 4
[April 18, 15:45-17:15 Rm.103]
|
|
| What Is OMT (Optimal Medical Therapy) in Real World Practice |
| Chairpersons |
정명호, 박헌식 |
| Panel |
김상현, 나득영, 배장호, 주형준, 허승호 |
| 15:45-16:02 |
How to Treat a Patient with Silent Nonobstructive Coronary Artery Disease in Coronary CT |
신상훈/일산병원 |
| 16:02-16:19 |
How to Treat a Patient Intolerant to Aspirin After PCI: Short-Term and Long-Term Therapy |
한주용/성균관의대 |
| 16:19-16:36 |
How to Treat a Patient Intolerant to Moderate Intensity Statin Who Is Proven ASCVD |
윤경호/원광의대 |
| 16:36-16:53 |
How to Treat a Patient without Chest Pain After PCI ; Beta-Blocker First or RAS Inhibitor First? |
양태현/인제의대 |
| 16:53-17:15 |
Discussion |
|
|